Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Louis M Aledort"'
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 26:492-503
Research describing patient experience and outcomes with extended half-life recombinant factor VIII (EHL rFVIII) outside of clinical trials is limited. Real-world rFVIII consumption studies, when people with hemophilia A (PWHA) switch from standard h
Publikováno v:
Haemophilia. 27
Autor:
Louis M. Aledort, Giovanni Di Minno, Pier Mannuccio Mannucci, James W. Ironside, Lutz Gürtler, Carlo Federico Perno
Publikováno v:
Di Minno, G, Mannucci, P M, Ironside, J W, Perno, C F, Gürtler, L & Aledort, L 2020, ' Convalescent plasma for administration of passive antibodies against viral agents ', Haematologica, vol. 105, no. 12, pp. 2710-2715 . https://doi.org/10.3324/haematol.2020.267427
Autor:
Louis M, Aledort
Publikováno v:
The New England journal of medicine. 382(8)
Publikováno v:
Expert Opinion on Drug Safety. 17:1233-1237
Patients affected by hemophilia A often require frequent prophylactic and therapeutic self-infusion. For those who develop inhibitors, treatment options are limited and mortality is increased. Emicizumab, a bispecific antibody to Factors IXa and X th
Autor:
Alexa Punzalan, Jeffrey Glassberg, Adeeb Rahman, Louis M. Aledort, Juan J. Badimon, Caroline Cromwell, Mohammad Urooj Zafar
Publikováno v:
J Immunol Methods
Sickle cell disease (SCD) is a genetic disease caused by mutations in the beta globin gene, and inflammation plays a key role in driving many aspects of disease pathology. Early immune activation is believed to be associated with hemodynamic stresses
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:524-527
Congenital thrombotic thrombocytopenia purpura (cTTP) is a very rare disorder worldwide. Standard treatment of recognized cases has been to administer fresh frozen plasma as the source of ADAMTS13, to replenish the absent ADAMTS13 enzyme. An alternat
Autor:
Louis M. Aledort
Publikováno v:
Haemophilia. 22:676-683
The establishment of dedicated comprehensive treatment centres more than a half century ago transformed the management of haemophilia in the United States. Formerly, a disease associated with crippling disability and premature death, today, persons w
Autor:
Adam Cuker, Guy Young, Michael Recht, Shannon L. Carpenter, Roshni Kulkarni, Louis M. Aledort, Cindy A. Leissinger
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 25(3)
Autor:
Louis M. Aledort
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 25(2)